CDC25A pathway toward tumorigenesis: Molecular targets of CDC25A in cell‐cycle regulation. Issue 3 (15th November 2018)
- Record Type:
- Journal Article
- Title:
- CDC25A pathway toward tumorigenesis: Molecular targets of CDC25A in cell‐cycle regulation. Issue 3 (15th November 2018)
- Main Title:
- CDC25A pathway toward tumorigenesis: Molecular targets of CDC25A in cell‐cycle regulation
- Authors:
- Sadeghi, Hossein
Golalipour, Masoud
Yamchi, Ahad
Farazmandfar, Touraj
Shahbazi, Majid - Abstract:
- Abstract: The cell division cycle 25 (CDC25) phosphatases regulate key transitions between cell‐cycle phases during normal cell division, and in the case of DNA damage, they are key targets of the checkpoint machinery that ensure genetic stability. Little is known about the mechanisms underlying dysregulation and downstream targets of CDC25. To understand these mechanisms, we silenced the CDC25A gene in breast cancer cell line MDA‐MB‐231 and studied downstream targets of CDC25A gene. MDA‐MB‐231 breast cancer cells were transfected and silenced by CDC25A small interfering RNA. Total messenger RNA (mRNA) was extracted and analyzed by quantitative real‐time polymerase chain reaction. CDC25A phosphatase level was visualized by Western blot analysis and was analyzed by 2D electrophoresis and LC‐ESI‐MS/MS. After CDC25A silencing, cell proliferation reduced, and the expression of 12 proteins changed. These proteins are involved in cell‐cycle regulation, programmed cell death, cell differentiation, regulation of gene expression, mRNA editing, protein folding, and cell signaling pathways. Five of these proteins, including ribosomal protein lateral stalk subunit P0, growth factor receptor bound protein 2, pyruvate kinase muscle 2, eukaryotic translation elongation factor 2, and calpain small subunit 1 increase the activity of cyclin D1. Our results suggest that CDC25A controls the cell proliferation and tumorigenesis by a change in expression of proteins involved in cyclin D1Abstract: The cell division cycle 25 (CDC25) phosphatases regulate key transitions between cell‐cycle phases during normal cell division, and in the case of DNA damage, they are key targets of the checkpoint machinery that ensure genetic stability. Little is known about the mechanisms underlying dysregulation and downstream targets of CDC25. To understand these mechanisms, we silenced the CDC25A gene in breast cancer cell line MDA‐MB‐231 and studied downstream targets of CDC25A gene. MDA‐MB‐231 breast cancer cells were transfected and silenced by CDC25A small interfering RNA. Total messenger RNA (mRNA) was extracted and analyzed by quantitative real‐time polymerase chain reaction. CDC25A phosphatase level was visualized by Western blot analysis and was analyzed by 2D electrophoresis and LC‐ESI‐MS/MS. After CDC25A silencing, cell proliferation reduced, and the expression of 12 proteins changed. These proteins are involved in cell‐cycle regulation, programmed cell death, cell differentiation, regulation of gene expression, mRNA editing, protein folding, and cell signaling pathways. Five of these proteins, including ribosomal protein lateral stalk subunit P0, growth factor receptor bound protein 2, pyruvate kinase muscle 2, eukaryotic translation elongation factor 2, and calpain small subunit 1 increase the activity of cyclin D1. Our results suggest that CDC25A controls the cell proliferation and tumorigenesis by a change in expression of proteins involved in cyclin D1 regulation and G1/S transition. Abstract : The cell division cycle 25 (CDC25) phosphatases regulate key transitions between cell‐cycle phases. We silenced the CDC25A gene in breast cancer cell line MDA‐MB‐231 and studied downstream targets of CDC25A gene. In conclusion, CDC25A controls the cell proliferation and tumorigenesis by a change in expression of proteins involved in cyclin D1 regulation and G1/S transition. … (more)
- Is Part Of:
- Journal of cellular biochemistry. Volume 120:Issue 3(2019)
- Journal:
- Journal of cellular biochemistry
- Issue:
- Volume 120:Issue 3(2019)
- Issue Display:
- Volume 120, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 120
- Issue:
- 3
- Issue Sort Value:
- 2019-0120-0003-0000
- Page Start:
- 2919
- Page End:
- 2928
- Publication Date:
- 2018-11-15
- Subjects:
- breast cancer -- CDC25A -- cell‐cycle -- cyclin D1
Cytochemistry -- Periodicals
572 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4644 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jcb.26838 ↗
- Languages:
- English
- ISSNs:
- 0730-2312
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.010000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 27134.xml